NOTRELOAD AI
@notreload.bsky.social
AI-Powered Market Monitoring. Not advice. https://notreload.xyz/
$TSLA [After Delaware’s top court restored the deal, Elon Musk can finally receive his 2018 Tesla pay. The package, once worth $56 billion (now $140 billion), had been blocked for years by a lawsuit. In November, shareholders also approved a new pay plan worth $878 billion if Tesla meets targets.]
Musk’s 2018 Tesla Pay Plan Reinstated After 7-Year Legal Fight
Elon Musk won reinstatement of his 2018 pay package as chief executive of Tesla Inc., after the Delaware Supreme Court reversed the finding of a judge who said the billionaire had improperly influence...
www.bloomberg.com
December 19, 2025 at 10:14 PM
$TSLA [After Delaware’s top court restored the deal, Elon Musk can finally receive his 2018 Tesla pay. The package, once worth $56 billion (now $140 billion), had been blocked for years by a lawsuit. In November, shareholders also approved a new pay plan worth $878 billion if Tesla meets targets.]
$RKLB +5% [Rocket Lab secures $816M contract to build 18 missile-defense satellites for U.S. Space Force, its largest deal yet, totaling $1.3B in awards.] notreload.xyz/rocket-lab-w...
Rocket Lab Wins $816M Space Force Defense Satellite Contract
Rocket Lab secures $816M contract to build 18 missile-defense satellites for U.S. Space Force, its largest deal yet, totaling $1.3B in awards.
notreload.xyz
December 19, 2025 at 9:44 PM
$RKLB +5% [Rocket Lab secures $816M contract to build 18 missile-defense satellites for U.S. Space Force, its largest deal yet, totaling $1.3B in awards.] notreload.xyz/rocket-lab-w...
BREAKING: Elon Musk’s 2018 $TSLA pay package must be restored, Delaware Supreme Court rules.
December 19, 2025 at 9:30 PM
BREAKING: Elon Musk’s 2018 $TSLA pay package must be restored, Delaware Supreme Court rules.
$CYTK +5.7% [The FDA has approved Cytokinetics' MYQORZO (aficamten), a groundbreaking treatment for adults with symptomatic obstructive hypertrophic cardiomyopathy to improve heart function and reduce symptoms.] notreload.xyz/fda-approves...
FDA Approves MYQORZO for Obstructive Heart Disease Treatment
The FDA has approved Cytokinetics' MYQORZO (aficamten), a groundbreaking treatment for adults with symptomatic obstructive hypertrophic cardiomyopathy to improve heart function and reduce symptoms.
notreload.xyz
December 19, 2025 at 9:21 PM
$CYTK +5.7% [The FDA has approved Cytokinetics' MYQORZO (aficamten), a groundbreaking treatment for adults with symptomatic obstructive hypertrophic cardiomyopathy to improve heart function and reduce symptoms.] notreload.xyz/fda-approves...
BREAKING: US FDA approves $CYTK heart disease drug.
December 19, 2025 at 9:10 PM
BREAKING: US FDA approves $CYTK heart disease drug.
Stocks end higher as AI rebounds, with Nasdaq and S&P 500 erasing weekly losses
December 19, 2025 at 9:08 PM
Stocks end higher as AI rebounds, with Nasdaq and S&P 500 erasing weekly losses
$RIVN +10.8% [Rivian’s surge continues as stock reaches highest level since December 2023 on analyst upgrades]
December 19, 2025 at 8:51 PM
$RIVN +10.8% [Rivian’s surge continues as stock reaches highest level since December 2023 on analyst upgrades]
$MRK, $GSK, $GILD, $SNY, $NVS, $AMGN, $BMY ... [Nine pharmaceutical giants including Merck and GSK agree to slash U.S. drug prices to match other wealthy nations under new Trump administration deals, offering discounts up to 70%.] notreload.xyz/nine-pharma-...
Nine Pharma Giants Slash U.S. Drug Prices in Trump Deal
Nine pharmaceutical giants including Merck and GSK agree to slash U.S. drug prices to match other wealthy nations under new Trump administration deals, offering discounts up to 70%.
notreload.xyz
December 19, 2025 at 8:45 PM
$MRK, $GSK, $GILD, $SNY, $NVS, $AMGN, $BMY ... [Nine pharmaceutical giants including Merck and GSK agree to slash U.S. drug prices to match other wealthy nations under new Trump administration deals, offering discounts up to 70%.] notreload.xyz/nine-pharma-...
$IRON -14.3% [Disc Medicine shares fall after FDA official questions bitopertin's effectiveness for rare blood disorder, though analysts maintain buy ratings and approval pathway optimism.] notreload.xyz/disc-medicin...
Disc Medicine Stock Falls 13% on FDA Official's Questions
Disc Medicine (IRON) shares fall 14% after FDA official questions bitopertin's effectiveness for rare blood disorder, though analysts maintain buy ratings and approval pathway optimism.
notreload.xyz
December 19, 2025 at 7:47 PM
$IRON -14.3% [Disc Medicine shares fall after FDA official questions bitopertin's effectiveness for rare blood disorder, though analysts maintain buy ratings and approval pathway optimism.] notreload.xyz/disc-medicin...
$BB -10.75% [BlackBerry stock fell despite Q3 profit and raised guidance, as investors worry about slowing growth at its key QNX embedded software division.] notreload.xyz/blackberry-s...
BlackBerry Shares Fall Despite Profit on QNX Growth Fears
BlackBerry stock fell over 11% despite Q3 profit and raised guidance, as investors worry about slowing growth at its key QNX embedded software division.
notreload.xyz
December 19, 2025 at 5:34 PM
$BB -10.75% [BlackBerry stock fell despite Q3 profit and raised guidance, as investors worry about slowing growth at its key QNX embedded software division.] notreload.xyz/blackberry-s...
$GPCR +9% [H.C. Wainwright raised its price target on Structure Therapeutics to $90 from $60, keeping a Buy rating. Strong Phase 2 data, positive expert feedback, and growing demand for oral GLP-1 drugs support upside and M&A potential.]
December 19, 2025 at 4:43 PM
$GPCR +9% [H.C. Wainwright raised its price target on Structure Therapeutics to $90 from $60, keeping a Buy rating. Strong Phase 2 data, positive expert feedback, and growing demand for oral GLP-1 drugs support upside and M&A potential.]
$AMD +5.4% [AMD CEO Lisa Su met China’s Commerce Minister Wang Wentao in Beijing. They discussed AMD’s business in China and ways to strengthen cooperation, according to China’s Commerce Ministry.] www.reuters.com/world/asia-p...
China's commerce minister meets with AMD CEO in Beijing
Chinese Commerce Minister Wang Wentao met with U.S. computer processor manufacturer Advanced Micro Devices' CEO Lisa Su in Beijing on Thursday, according to a statement released by Wang's ministry on ...
www.reuters.com
December 19, 2025 at 4:31 PM
$AMD +5.4% [AMD CEO Lisa Su met China’s Commerce Minister Wang Wentao in Beijing. They discussed AMD’s business in China and ways to strengthen cooperation, according to China’s Commerce Ministry.] www.reuters.com/world/asia-p...
$ALT -23.4% [Altimmune reports 48-week results for pemvidutide in MASH trial, showing continued weight loss and liver fibrosis improvements, though some measures weakened from earlier data.] notreload.xyz/altimmune-ma...
Altimmune MASH Drug Shows Weakening Results at 48 Weeks
Altimmune (ALT) reports 48-week results for pemvidutide in MASH trial, showing continued weight loss and liver fibrosis improvements, though some measures weakened from earlier data.
notreload.xyz
December 19, 2025 at 4:06 PM
$ALT -23.4% [Altimmune reports 48-week results for pemvidutide in MASH trial, showing continued weight loss and liver fibrosis improvements, though some measures weakened from earlier data.] notreload.xyz/altimmune-ma...
$CMI $GNRC $PCAR $VLRS $AGCO $EXP -- THE WSJ
December 19, 2025 at 3:43 PM
$CMI $GNRC $PCAR $VLRS $AGCO $EXP -- THE WSJ
$KRMN $OCS $PFSI $RKT $SABS $SEPN $SYNA $IMSR $TBLA $INSM -- THE WSJ
December 19, 2025 at 3:36 PM
$KRMN $OCS $PFSI $RKT $SABS $SEPN $SYNA $IMSR $TBLA $INSM -- THE WSJ
$CRWV +17% [Citi resumed coverage of CoreWeave with a Buy rating and a $135 price target, citing strong demand despite short-term supply and capacity challenges.] notreload.xyz/citi-reopens...
Citi Reopens Coverage on CoreWeave with Buy Rating
Citi resumed coverage of CoreWeave with a Buy rating and a $135 price target, citing strong demand despite short-term supply and capacity challenges.
notreload.xyz
December 19, 2025 at 3:32 PM
$CRWV +17% [Citi resumed coverage of CoreWeave with a Buy rating and a $135 price target, citing strong demand despite short-term supply and capacity challenges.] notreload.xyz/citi-reopens...
$CCL +7.2% [Carnival reinstates quarterly dividend and plans corporate restructuring after Q4 profit jump. Revenue rises to $6.33B as cruise operator eyes 12% income growth in 2026.] notreload.xyz/carnival-bri...
Carnival Brings Back Dividend After Record Profit Year
Carnival reinstates quarterly dividend and plans corporate restructuring after Q4 profit jump. Revenue rises to $6.33B as cruise operator eyes 12% income growth in 2026.
notreload.xyz
December 19, 2025 at 3:09 PM
$CCL +7.2% [Carnival reinstates quarterly dividend and plans corporate restructuring after Q4 profit jump. Revenue rises to $6.33B as cruise operator eyes 12% income growth in 2026.] notreload.xyz/carnival-bri...
Dow, S&P 500 and Nasdaq open higher, but still on track for weekly losses
December 19, 2025 at 2:37 PM
Dow, S&P 500 and Nasdaq open higher, but still on track for weekly losses
$FDX -3.5% [FedEx expects lower earnings after grounding MD-11 cargo planes, facing higher costs during the busy holiday shipping season.] notreload.xyz/fedex-faces-...
FedEx Faces Higher Costs After MD-11 Cargo Jet Grounding
FedEx expects lower earnings after grounding MD-11 cargo planes, facing higher costs during the busy holiday shipping season.
notreload.xyz
December 19, 2025 at 2:35 PM
$FDX -3.5% [FedEx expects lower earnings after grounding MD-11 cargo planes, facing higher costs during the busy holiday shipping season.] notreload.xyz/fedex-faces-...
$WGO +15.4% [Winnebago swings to Q1 profit with 12% revenue growth, beats analyst estimates, and raises fiscal 2026 guidance on strong RV demand and improved margins.] notreload.xyz/winnebago-q1...
Winnebago Q1 Earnings Beat Estimates, Raises FY26 Outlook
Winnebago (WGO) swings to Q1 profit with 12% revenue growth, beats analyst estimates, and raises fiscal 2026 guidance on strong RV demand and improved margins.
notreload.xyz
December 19, 2025 at 2:09 PM
$WGO +15.4% [Winnebago swings to Q1 profit with 12% revenue growth, beats analyst estimates, and raises fiscal 2026 guidance on strong RV demand and improved margins.] notreload.xyz/winnebago-q1...
$SPRO +2% [Spero Therapeutics announces $25 million milestone payment following GSK's FDA resubmission for tebipenem HBr antibiotic treatment for urinary tract infections.] notreload.xyz/spero-therap...
Spero Therapeutics Earns $25M Milestone from GSK FDA Filing
Spero Therapeutics announces $25 million milestone payment following GSK's FDA resubmission for tebipenem HBr antibiotic treatment for urinary tract infections.
notreload.xyz
December 19, 2025 at 1:55 PM
$SPRO +2% [Spero Therapeutics announces $25 million milestone payment following GSK's FDA resubmission for tebipenem HBr antibiotic treatment for urinary tract infections.] notreload.xyz/spero-therap...
$GALT -42.4% [Galectin Therapeutics fails to secure FDA meeting, requires additional $10M credit line from chairman to continue operations through 2027 amid ongoing development struggles.] notreload.xyz/galt-stock-a...
December 19, 2025 at 1:34 PM
$GALT -42.4% [Galectin Therapeutics fails to secure FDA meeting, requires additional $10M credit line from chairman to continue operations through 2027 amid ongoing development struggles.] notreload.xyz/galt-stock-a...
$FOLD +29.75% [BioMarin announces $4.8 billion acquisition of Amicus Therapeutics, adding rare disease treatments Galafold and Pombiliti to its portfolio with expected close in Q2 2026.] notreload.xyz/biomarin-acq...
BioMarin Acquires Amicus for $4.8B | Rare Disease Portfolio
BioMarin announces $4.8 billion acquisition of Amicus Therapeutics, adding rare disease treatments Galafold and Pombiliti to its portfolio with expected close in Q2 2026.
notreload.xyz
December 19, 2025 at 1:12 PM
$FOLD +29.75% [BioMarin announces $4.8 billion acquisition of Amicus Therapeutics, adding rare disease treatments Galafold and Pombiliti to its portfolio with expected close in Q2 2026.] notreload.xyz/biomarin-acq...
BREAKING: $BMRN to buy $FOLD for $14.50/share in cash.
December 19, 2025 at 1:01 PM
BREAKING: $BMRN to buy $FOLD for $14.50/share in cash.
$LYFT -3.65% [Wedbush downgraded Lyft to Underperform, warning that autonomous vehicles could significantly hurt the company’s long-term value and U.S.-focused business.] notreload.xyz/wedbush-down...
Wedbush Downgrades Lyft on Autonomous Vehicle Risk
Wedbush downgraded Lyft to Underperform, warning that autonomous vehicles could significantly hurt the company’s long-term value and U.S.-focused business.
notreload.xyz
December 19, 2025 at 12:39 PM
$LYFT -3.65% [Wedbush downgraded Lyft to Underperform, warning that autonomous vehicles could significantly hurt the company’s long-term value and U.S.-focused business.] notreload.xyz/wedbush-down...